Browse by subject
Lung Cancer: Translational and Emerging Therapies
Series: Translational Medicine
- Dr Kishan J. Pandya (University of Rochester, Rochester, NY, USA)
- Dr Julie R. Brahmer (The John Hopkins University, Baltimore, MD, USA)
- Dr Manuel Hidalgo (The John Hopkins University, Baltimore, MD, USA)
- Pub Date
- May 2007
- Series
- Translational Medicine
- Volume
- 3
- Pages
- 280
- Size
- 6 x 9
- ISBN
- 9780849390210, 0849390214
Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy.
Acquainting specialists with recent progress in the development of new and effective therapies for disease control, this source covers:
• scientific principles, trial results, and clinical implications of emerging and translational therapies and prognostic/predictive markers
• new therapies for optimizing patient outcomes
• emerging therapies such as antiangiogensis and EGFR inhibitors, tumor vaccines, monoclonal antibodies, endothelial receptor antagonists, and combination therapies involving established treatments
• current and future targets of therapy, trial design, and patient selection
More products like this:
- Breast Cancer: Translational Therapeutic Strategies
- Prostate Cancer: Translational and Emerging Therapies
- Melanoma: Transitional Research and Emerging Therapies
- Lung Cancer Therapy Annual 6
- Cancer Vaccines: Challenges and Opportunities in Translation
- Diabetes: Translating Research into Practice
- Multiple Myeloma: Translational and Emerging Therapies
- Targeted Therapies in Oncology
- Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment
- Multiple Sclerosis Therapeutics, Third Edition
